Demographic and psychiatric correlates of compulsive sexual behaviors in gambling disorder

Imagem de Miniatura
Arquivos
art_COWIE_Demographic_and_psychiatric_correlates_of_compulsive_sexual_behaviors_2019.PDF (192.31 KB)
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
AKADEMIAI KIADO ZRT
Autores
COWIE, Megan E.
KIM, Hyoun S.
HODGINS, David C.
MCGRATH, Daniel S.
Citação
JOURNAL OF BEHAVIORAL ADDICTIONS, v.8, n.3, p.451-462, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and aims: Gambling disorder (GD) and compulsive sexual behavior (CSB) may commonly co-occur. Yet, the psychiatric correlates of these co-occurring disorders are an untapped area of empirical scrutiny, limiting our understanding of appropriate treatment modalities for this dual-diagnosed population. This study examined the demographic and clinical correlates of CSB in a sample of treatment-seeking individuals with GD (N = 368) in Sao Paulo, Brazil. Methods: Psychiatrists and psychologists conducted semi-structured clinical interviews to identify rates of CSB and other comorbid psychiatric disorders. The Shorter PROMIS Questionnaire was administered to assess additional addictive behaviors. The TCI and BIS-11 were used to assess facets of personality. Demographic and gambling variables were also assessed. Results: Of the total sample, 24 (6.5%) met diagnostic criteria for comorbid CSB (GD + CSB). Compared to those without compulsive sexual behaviors (GD - CSB), individuals with GD + CSB were more likely to be younger and male. No differences in gambling involvement emerged. Individuals with GD + CSB tended to have higher rates of psychiatric disorders (depression, post-traumatic stress disorder, and bulimia nervosa) and engage in more addictive behaviors (problematic alcohol use, drug use, and exercise) compared to GD - CSB. Those with GD + CSB evidenced less self-directedness, cooperativeness, self-transcendence, and greater motor impulsivity. Logistic regression showed that the predictors of GD + CSB, which remained in the final model, were being male, a diagnosis of bulimia, greater gambling severity, and less self-transcendence. Discussion and conclusion: Given those with GD + CSB evidence greater psychopathology, greater attention should be allocated to this often under studied comorbid condition to ensure adequate treatment opportunities.
Palavras-chave
gambling disorder, compulsive sexual behaviors, comorbidity, clinical correlates
URI
https://observatorio.fm.usp.br/handle/OPI/34087
Referências
  1. Abdollahnejad R, 2014, ADDICT BEHAV, V39, P566, DOI 10.1016/j.addbeh.2013.11.004
  2. Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106
  3. APA, 1994, DIAGN STAT MAN MENT
  4. APA [American Psychiatric Association], 2013, DIAGN STAT MAN MENT
  5. Bancroft J, 2004, J SEX RES, V41, P225, DOI 10.1080/00224490409552230
  6. Basiaux P, 2001, ALCOHOL ALCOHOLISM, V36, P584, DOI 10.1093/alcalc/36.6.584
  7. Berg KC, 2013, J ABNORM PSYCHOL, V122, P111, DOI 10.1037/a0029703
  8. Billieux J, 2015, J BEHAV ADDICT, V4, P119, DOI 10.1556/2006.4.2015.009
  9. Black DW, 2015, J GAMBL STUD, V31, P1201, DOI 10.1007/s10899-014-9505-y
  10. Black DW, 1997, AM J PSYCHIAT, V154, P243
  11. Black DW, 1998, PSYCHIATR SERV, V49, P1434, DOI 10.1176/ps.49.11.1434
  12. Blaszczynski A, 2002, ADDICTION, V97, P487, DOI 10.1046/j.1360-0443.2002.00015.x
  13. Boothby CA, 2017, ADDICT BEHAV, V70, P35, DOI 10.1016/j.addbeh.2017.02.002
  14. Cashwell CS, 2017, INT J MENT HEALTH AD, V15, P16, DOI 10.1007/s11469-016-9646-6
  15. Chatzittofis A, 2016, PSYCHONEUROENDOCRINO, V63, P247, DOI 10.1016/j.psyneuen.2015.10.002
  16. Christo G, 2003, ADDICT BEHAV, V28, P225, DOI 10.1016/S0306-4603(01)00231-3
  17. Cloninger R, 1994, TEMPERAMENT CHARACTE
  18. Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211
  19. Cunningham-Williams R M, 2000, J Gambl Stud, V16, P347
  20. Cyders MA, 2008, PSYCHOL BULL, V134, P807, DOI 10.1037/a0013341
  21. de Vries SK, 2016, EUR EAT DISORD REV, V24, P518, DOI 10.1002/erv.2470
  22. do Amaral MLS, 2015, J SEX MED, V12, P557, DOI 10.1111/jsm.12761
  23. Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481
  24. Farre JM, 2015, COMPR PSYCHIAT, V56, P59, DOI 10.1016/j.comppsych.2014.10.002
  25. Farstad SM, 2015, PSYCHOL ADDICT BEHAV, V29, P805, DOI 10.1037/adb0000069
  26. Fischer S, 2008, PERS INDIV DIFFER, V44, P789, DOI 10.1016/j.paid.2007.10.008
  27. Forbush KT, 2008, CNS SPECTRUMS, V13, P306, DOI 10.1017/S1092852900016424
  28. Fuentes D., 2000, ESCALAS AVALIACAO CL, P363
  29. Galetti AM, 2017, REV BRAS PSIQUIATR, V39, P36, DOI 10.1590/1516-4446-2016-1911
  30. Gonzalez-Bueso V, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040668
  31. Goodman A., 2001, SEXUAL ADDICTION COM, V8, P191, DOI 10.1080/107201601753459919
  32. Goodman A, 2005, SUBSTANCE ABUSE, P505
  33. Granero R, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00914
  34. Grant J. E., 2008, IMPULSE CONTROL DISO
  35. Grant JE, 2003, ACTA PSYCHIAT SCAND, V108, P203, DOI 10.1034/j.1600-0447.2003.00162.x
  36. Grant JE, 2002, COMPR PSYCHIAT, V43, P378, DOI 10.1053/comp.2002.34628
  37. Grant JE, 2005, SEX ADDICT COMPULS, V12, P235, DOI 10.1080/10720160500203856
  38. Griffiths M. D., 2005, J SUBST USE, V10, P191, DOI 10.1080/14659890500114359
  39. Hodgins DC, 2015, INT J MENT HEALTH AD, V13, P699, DOI 10.1007/s11469-015-9572-z
  40. Hodgins DC, 2011, LANCET, V378, P1874, DOI 10.1016/S0140-6736(10)62185-X
  41. Hodgins DC, 2010, J GAMBL STUD, V26, P117, DOI 10.1007/s10899-009-9137-9
  42. HOLLANDER E, 1993, PSYCHIAT ANN, V23, P355, DOI 10.3928/0048-5713-19930701-05
  43. Hollander E, 2005, INT J PSYCHIAT CLIN, V9, P79, DOI 10.1080/13651500510018347
  44. HOLLANDER E, 1995, J CLIN PSYCHIAT, V56, P3
  45. HOLLANDER E, 1995, J CLIN PSYCHIAT, V56, P7
  46. Hsieh YP, 2016, COMPUT HUM BEHAV, V56, P209, DOI 10.1016/j.chb.2015.11.048
  47. Janiri L, 2007, SUBST USE MISUSE, V42, P975, DOI 10.1080/10826080701202445
  48. Jauregui P, 2016, J BEHAV ADDICT, V5, P251, DOI 10.1556/2006.5.2016.038
  49. Jimenez-Murcia S, 2016, J GAMBL STUD, V32, P327, DOI 10.1007/s10899-015-9537-y
  50. Jimenez-Murcia S, 2014, BIOMED RES INT, DOI 10.1155/2014/315062
  51. Kafka MP, 2010, ARCH SEX BEHAV, V39, P377, DOI 10.1007/s10508-009-9574-7
  52. Kessler RC, 2008, PSYCHOL MED, V38, P1351, DOI 10.1017/S0033291708002900
  53. KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012
  54. Kim HS, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00406
  55. Kim SW, 2009, PSYCHIAT RES, V166, P76, DOI 10.1016/j.psychres.2007.11.008
  56. Kraus SW, 2016, ADDICTION, V111, P2097, DOI 10.1111/add.13297
  57. Kuhn S, 2014, JAMA PSYCHIAT, V71, P827, DOI 10.1001/jamapsychiatry.2014.93
  58. LACEY JH, 1986, BRIT J ADDICT, V81, P641
  59. Ladd GT, 2003, EXP CLIN PSYCHOPHARM, V11, P202, DOI 10.1037/1064-1297.11.3.202
  60. Leblond J, 2003, BRIT J CLIN PSYCHOL, V42, P205, DOI 10.1348/014466503321903607
  61. Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8
  62. Lorains FK, 2011, ADDICTION, V106, P490, DOI 10.1111/j.1360-0443.2010.03300.x
  63. Malloy-Diniz Leandro Fernandes, 2010, J. bras. psiquiatr., V59, P99, DOI 10.1590/S0047-20852010000200004
  64. Martinotti G, 2006, COMPR PSYCHIAT, V47, P350, DOI 10.1016/j.comppsych.2005.12.005
  65. Mauro PM, 2016, DRUG ALCOHOL DEPEN, V163, P108, DOI 10.1016/j.drugalcdep.2016.04.001
  66. MCELROY SL, 1994, J CLIN PSYCHIAT, V55, P33
  67. Mechelmans DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105476
  68. Miner MH, 2009, PSYCHIAT RES-NEUROIM, V174, P146, DOI 10.1016/j.pscychresns.2009.04.008
  69. Moon M, 2017, J GAMBL STUD, V33, P841, DOI 10.1007/s10899-016-9658-y
  70. Nordin C, 2007, J GAMBL STUD, V23, P113, DOI 10.1007/s10899-006-9049-x
  71. Parsons JT, 2013, J SEX MED, V10, P3088, DOI 10.1111/jsm.12117
  72. Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1
  73. Peluso MAM, 2007, J AFFECT DISORDERS, V100, P227, DOI 10.1016/j.jad.2006.09.037
  74. Petry NM, 2003, J NERV MENT DIS, V191, P399, DOI 10.1097/00005053-200306000-00008
  75. Politis M, 2013, BRAIN, V136, P400, DOI 10.1093/brain/aws326
  76. Raymond NC, 2003, COMPR PSYCHIAT, V44, P370, DOI 10.1016/S0010-440X(03)00110-X
  77. Reid RC, 2012, J SEX MED, V9, P2868, DOI 10.1111/j.1743-6109.2012.02936.x
  78. Sacks S, 2013, J SUBST ABUSE TREAT, V44, P488, DOI 10.1016/j.jsat.2012.11.001
  79. Scanavino MD, 2016, ARCH SEX BEHAV, V45, P207, DOI 10.1007/s10508-014-0356-5
  80. Shaffer HJ, 2004, HARVARD REV PSYCHIAT, V12, P367, DOI 10.1080/10673220490905705
  81. Smith GT, 2016, DRUG ALCOHOL DEPEN, V163, pS3, DOI 10.1016/j.drugalcdep.2015.08.038
  82. Steel Z, 1998, ADDICTION, V93, P895, DOI 10.1046/j.1360-0443.1998.93689511.x
  83. Steenbergh TA, 2002, PSYCHOL ADDICT BEHAV, V16, P143, DOI 10.1037//0893-164X.16.2.143
  84. Tabachnick B. G., 2007, USING MULTIVARIATE S
  85. Tagay S, 2014, EAT DISORD, V22, P33, DOI 10.1080/10640266.2014.857517
  86. Tavares H, 2003, J CLIN PSYCHIAT, V64, P433, DOI 10.4088/JCP.v64n0413
  87. Umberg EN, 2012, J CLIN PSYCHOPHARM, V32, P376, DOI 10.1097/JCP.0b013e318252464f
  88. Voon V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102419
  89. Williams AD, 2012, BRIT J CLIN PSYCHOL, V51, P223, DOI 10.1111/j.2044-8260.2011.02022.x

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/23